OFFICIAL PUBLICATION OF

by its subsidiary APPco

A return to ‘pre-pandemic levels’

Sheshtyn Paola 15/07/2022

business matching - connecting puzzle elements

Shortages of intravenous and subcutaneous Actemra have been resolved as pharmacists thanked for their patience A shortage of Actemra (tocilizumab) has finally been resolved after supply was battered following recommendations last year by the World Health Organisation (WHO) for the drug to be used as a treatment for patients seriously ill COVID-19. In July last

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

A return to ‘pre-pandemic levels’

Previous ‘He’s not an expert in diagnosis, he’s not an expert in management.’

Next Back on the calendar

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous ‘He’s not an expert in diagnosis, he’s not an expert in management.’

Next Back on the calendar

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.